Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study
Background: In spite of laser being the gold standard treatment for Diabetic Macular edema (DME), some patients do not respond to laser. Various treatment modalities are being tried in the management of refractory diffuse DME (DDME). Purpose: To compare the efficacy of intravitreal bevacizumab (IVB...
Main Authors: | Rajvardhan Azad, Siddarth Sain, Yog Raj Sharma, Deepankur Mahajan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Oman Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ojoonline.org/article.asp?issn=0974-620X;year=2012;volume=5;issue=3;spage=166;epage=170;aulast=Azad |
Similar Items
-
Clinical analysis of intravitreal injection of triamcinolone acetonide combined macular grid photocoagulation treatment for macular edema
by: Xian-Hua Jing, et al.
Published: (2014-10-01) -
Intravitreal Bevacizumab with or without Triamcinolone for Refractory Diabetic Macular Edema: Long-term Results of a Clinical Trial
by: Nasser Shoeibi, et al.
Published: (2013-01-01) -
Combined intravitreal bevacizumab and posterior sub-Tenon’s triamcinolone acetonide injections for persistent diabetic macular edema
by: Mona M Aly, et al.
Published: (2017-01-01) -
Combined Treatment with Bevacizumab and Triamcinolone Acetonide for Macular Edema Due to Retinal Vein Occlusion
by: Maja Vinković, et al.
Published: (2020-01-01) -
Intravitreal injection of conbercept combined with triamcinolone acetonide for diabetic macular edema
by: Jun Li<sup>*</sup>, et al.
Published: (2019-03-01)